The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer.
GA Pietersz , J Kanellos , MJ Smyth , J Zaicberg
Immunology and Cell Biology 65 ( 2) 111 -125
57
1987
Flare responses in small cell carcinoma of the lung.
W COSOLO , G MORSTYN , B ARKLES , A S ZIMET
Clinical Nuclear Medicine 13 ( 1) 13 -16
26
1988
Expression of mdr1 and mrp in the normal B‐cell homologue of B‐cell chronic lymphocytic leukaemia
D. M. P. WALL , S. EL‐OSTA , D. TZELEPIS , I. BERTONCELLO
British Journal of Haematology 96 ( 4) 697 -707
10
1997
The role of chemotherapy in malignant thymoma.
M. L. COPERCHINI , J. R. ZALCBERG
Australian and New Zealand Journal of Medicine 26 ( 3) 423 -423
1
1996
Gemcitabine and the blood brain barrier.
J. R. DAVIS , C. FERNANDES , J. R. ZALCBERG
Australian and New Zealand Journal of Medicine 29 ( 6) 831 -832
10
1999
Tumour visualisation using a radiolabelled monoclonal antibody.
J. R. ZALCBERG , C. H. THOMPSON , M. LICHTENSTEIN , M. J. LEYDEN
Australian and New Zealand Journal of Medicine 13 ( 6) 571 -577
6
1983
HYBRIDOMAS AND MONOCLONAL ANTIBODIES: APPLICATIONS IN ONCOLOGY
J. R. ZALCBERG , I. F. C. MCKENZIE
Australian and New Zealand Journal of Surgery 52 ( 4) 431 -438
3
1982
Migraine following the use of a 5‐hydroxytryptamine antagonist
J. SIDEROV , J. ZALCBERG , B. CHAMBERS , G. FABINYI
Australian and New Zealand Journal of Medicine 23 ( 5) 527 -528
2
1993
Liver transplantation in metastatic carcinoid tumour.
M. L. COPERCHINI , R. JONES , P. ANGUS , A. READ
Australian and New Zealand Journal of Medicine 26 ( 5) 702 -704
5
1996
A Phase I/II Study of the Intralesional Injection of Ricin-Monoclonal Antibody Conjugates in Patients with Hepatic Metastases
J.R Zalcberg , G Pietersz , B Toohey , J Laird
European Journal of Cancer 30 ( 9) 1227 -1231
21
1994
Consensus approaches to best practice management of gastrointestinal stromal tumors
John R ZALCBERG , Jayesh DESAI , Bruce MANN , Stephen FOX
Asia-pacific Journal of Clinical Oncology 4 ( 4) 188 -198
5
2008
What constitutes a multidisciplinary team meeting
Dr Linda MILESHKIN , Professor John ZALCBERG
Asia-pacific Journal of Clinical Oncology 7 ( 3) 317 -317
1
2011
Dose optimization of tyrosine kinase inhibitors to improve outcomes in GIST
John R. ZALCBERG , Jayesh DESAI
Asia-pacific Journal of Clinical Oncology 8 ( 1) 43 -52
5
2012
USE OF REAL-WORLD DATA AND REAL-WORLD EVIDENCE TO SUPPORT DRUG REIMBURSEMENT DECISION-MAKING IN ASIA
Lydia Wenxin LIN , Jeonghoon AHN , Diana Beatriz S BAYANI , Kelvin CHAN
3
TOMUDEX (ZD1694), A NOVEL AND SPECIFIC THYMIDYLATE SYNTHASE INHIBITOR HAS PROMISING ACTIVITY IN ADVANCED COLORECTAL-CANCER
E VANCUTSEM , D CUNNINGHAM , J ZALCBERG , E FRANCOIS
GASTROENTEROLOGY 108 ( 4) A548 -A548
1995
Traitement des tumeurs stromales digestives par l’imatinib
J VERWEIJ , PG CASALI , J ZALCBERG , A LECESNE
Gastroenterol Clin Biol 29 621 -625
2005
PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF LYMPHOMA CELL-LINES
J ZALCBERG , M TWEEDDALE , G CHEN , B LIM
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 26 ( MAR) 183 -183
1985
TUMOR-ASSOCIATED ANTIGEN RECOGNIZED BY MONOCLONAL-ANTIBODY-A MURINE MODEL SYSTEM FOR THE USE OF MONOCLONAL-ANTIBODIES IN THE INVIVO TREATMENT OF CANCER
S KOCH , J ZALCBERG , IF MCKENZIE
IMMUNOBIOLOGY 165 ( 3-4) 301 -301
1983
Novel heparanase inhibitor PI-88 extends disease free survival in a randomized phase II adjuvant clinical trial in patients with hepatocellular carcinoma (HCC) after curative resection
PJ Chen , PH Lee , DY Lin , CC Wu
Journal of Hepatology 46 S29 -3
1
2007
Adjuvant therapy for rectal cancer
John Zalcberg , Michael Michael , Kian F. Foo
Seminars in Colon and Rectal Surgery 13 ( 4) 259 -268
2002